<?xml version="1.0" encoding="ISO-8859-1"?><rss version="2.0"><channel><title>medsurfnews.com</title><link>http://www.medsurfnews.com</link><description>Last resources from Medsurfnews.com</description><language>it</language><pubDate></pubDate><copyright>Healthware.it</copyright><webmaster>francesco.raimondo@healthware.it</webmaster><image><title>Medsurfnews Rss</title><url>http://www.medsurfnews.com/images/logo.jpg</url><link>http://www.medsurfnews.com</link></image>
	
	
	
<item>
<category>Endocrinology</category>
<title>Vitamin D and Mortality</title>
<link>http://www.medsurfnews.com/contents/en/7097/display/vitamin-d-and-mortality.aspx</link>
<description><![CDATA[Supporters of the usefulness of vitamin D supplementation affirm that, beside improving bone metabolism, this vitamin is capable to produce beneficial effects also on other organs and systems, preventing the onset of various dysfunctions. For this reason, newer and newer trial are performed with the objective to verify these properties of vitamin D.]]></description>
<pubDate>Mon, 27 Feb 2012 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Endocrinology</category>
<title>Tiroxine and Cognitive Capability in Subclinical Hypothyroidism</title>
<link>http://www.medsurfnews.com/contents/en/6825/display/tiroxine-and-cognitive-capability-in-subclinical-hypothyroidism.aspx</link>
<description><![CDATA[In adults with subclinical hypothyroidism (increased TSH and normal fT4), is the administration of thyroxine supplementation capable to improve cognitive function? In order to answer this question, an English trial has been performed where 94 subjects over 64 years of age with subclinical hypothyroidism have been treated with thyroxine (up to TSH normalization) or placebo. ]]></description>
<pubDate>Mon, 31 Oct 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Endocrinology</category>
<title>Testosterone in Androgenic Deficiency</title>
<link>http://www.medsurfnews.com/contents/en/6761/display/testosterone-in-androgenic-deficiency.aspx</link>
<description><![CDATA[Since an American campaign for pharmaceutical information invites male subjects to address themselves to their general practitioner in the presence of low levels of testosterone, clearly promoting an “off label” use of this substance, as it were a sort of anti-age drug or, worse, a panacea, the Endocrine Society has updated its 2006 guidelines concerning the therapy for androgenic deficiency. ]]></description>
<pubDate>Mon, 10 Oct 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Endocrinology</category>
<title>Cell dysfunction linked to obesity and metabolic disorders</title>
<link>http://www.medsurfnews.com/contents/en/6757/display/cell-dysfunction-linked-to-obesity-and-metabolic-disorders.aspx</link>
<description><![CDATA[By measuring the radioactive isotope carbon-14, scientists have revealed an association between lipid cell dysfunction and diseases such as obesity, diabetes and blood lipid disorders. The study, which is presented in the journal Nature, can lead to new approaches to combating metabolic diseases.
]]></description>
<pubDate>Tue, 4 Oct 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Endocrinology</category>
<title>Testosterone in Elderly</title>
<link>http://www.medsurfnews.com/contents/en/6707/display/testosterone-in-elderly.aspx</link>
<description><![CDATA[The proposal to use testosterone in very old subjects is still nowadays under discussion, so every now and then researchers perform trials which should clear up this matter but they only increase confusion. It is the case of these new three trials: in the first one, performed in Europe, in order to identify the groups of symptoms associated with testosterone levels in 3369 males between 40 and 79 years of age, some questionnaires have been given and measurements of total and free basal plasmatic testosterone have been performed.]]></description>
<pubDate>Mon, 19 Sep 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Endocrinology</category>
<title>Impact of growth hormone therapy on adult height of children with idiopathic short stature</title>
<link>http://www.medsurfnews.com/contents/en/6264/display/impact-of-growth-hormone-therapy-on-adult-height-of-children-with-idiopathic-short-stature.aspx</link>
<description><![CDATA[To systematically determine the impact of growth hormone therapy on adult height of children with idiopathic short stature, a systematic review of the Cochrane Central Register of Controlled Trials, Medline, and the bibliographic references from retrieved articles of randomised and non-randomised controlled trials from 1985 to April 2010 has been performed. The analysis showed that Growth hormone therapy in children with idiopathic short stature seems to be effective in partially reducing the deficit in height as adults, although the magnitude of effectiveness is on average less than that achieved in other conditions for which growth hormone is licensed. The individual response to therapy is highly variable, and additional studies are needed to identify the responders. 
]]></description>
<pubDate>Mon, 14 Mar 2011 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Endocrinology</category>
<title>NICE recommends new treatment option for women at increased risk of osteoporotic fractures</title>
<link>http://www.medsurfnews.com/contents/en/5956/display/nice-recommends-new-treatment-option-for-women-at-increased-risk-of-osteoporotic-fractures.aspx</link>
<description><![CDATA[NICE recommends denosumab (Prolia) as a treatment option for certain postmenopausal women who are at increased risk of primary and secondary osteoporotic fractures if other treatments available on the NHS are unsuitable. Denosumab joins the range of treatments that NICE has already advised should be available on the NHS, to help stop a fracture from occurring in the first place, or to help women who have previously had a fracture.
]]></description>
<pubDate>Tue, 2 Nov 2010 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Endocrinology</category>
<title>Dark chocolate 'cuts cholesterol'</title>
<link>http://www.medsurfnews.com/contents/en/5873/display/dark-chocolate-cuts-cholesterol.aspx</link>
<description><![CDATA[An ingredient in dark chocolate could help diabetics reduce high cholesterol levels, a study claims.
]]></description>
<pubDate>Mon, 18 Oct 2010 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Endocrinology</category>
<title>Obesity scanner that only measures fat</title>
<link>http://www.medsurfnews.com/contents/en/5845/display/obesity-scanner-that-only-measures-fat.aspx</link>
<description><![CDATA[Researchers believe a new body scanner which measures body volume, rather than body mass, is more effective at identifying obesity.]]></description>
<pubDate>Wed, 13 Oct 2010 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	
<item>
<category>Endocrinology</category>
<title>Vitamin C May Improve Mood in Acutely Hospitalized Patients</title>
<link>http://www.medsurfnews.com/contents/en/5809/display/vitamin-c-may-improve-mood-in-acutely-hospitalized-patients.aspx</link>
<description><![CDATA[In a small, double-blind clinical trial, treating hypovitaminosis C improved the mood state of acutely hospitalized patients, the majority of whom had subnormal levels of vitamin C. ]]></description>
<pubDate>Tue, 5 Oct 2010 12:00:00 +0200</pubDate>
</item>	
	
	
	
	
	</channel></rss>
	



